Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota

Suxian Lin; Tao Zhang; Lingxiao Zhu; Kun Pang; Saisai Lu; Xin Liao; Senhong Ying; Lixia Zhu; Xin Xu; Jinyu Wu; Xiaobing Wang

doi:10.1016/j.jgg.2021.06.009

Volume 48 Issue 9

Sep. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2021 > 48(9): 781-791

PDF( 1728 KB)

Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota

doi: 10.1016/j.jgg.2021.06.009

a. Rheumatology Department, Wenzhou People's Hospital, Wenzhou, Zhejiang 325000, China;
b. State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, School of Life Sciences, Yunnan University, Kunming 650091, China;
c. Rheumatology Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China;
d. Institute of Genomic Medicine, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China;
e. Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China

Funds:

Financial support is from the Project of Zhejiang Provincial Department of Education, China (Y202045471) and the Project of Wenzhou Science and Technology, China (NO. Y2020205).

Received Date: 2021-05-23
Accepted Date: 2021-06-24
Rev Recd Date: 2021-06-22
Publish Date: 2021-07-09

Abstract

Abstract

Gut dysbiosis is suggested to play a critical role in the pathogenesis of gout. The aim of our study was to identify the characteristic dysbiosis of the gut microbiota in gout patients and the impact of a commonly used uric acid-lowering treatment, febuxostat on gut microbiota in gout. 16S ribosomal RNA sequencing and metagenomic shotgun sequencing was performed on fecal DNA isolated from 38 untreated gout patients, 38 gout patients treated with febuxostat, and 26 healthy controls. A restriction of gut microbiota biodiversity was detected in the untreated gout patients, and the alteration was partly restored by febuxostat. Biochemical metabolic indexes involved in liver and kidney metabolism were significantly associated with the gut microbiota composition in gout patients. Functional analysis revealed that the gut microbiome of gout patients had an enriched function on carbohydrate metabolism but a lower potential for purine metabolism, which was comparatively enhanced in the febuxostat treated gout patients. A classification microbial model obtained a high mean area under the curve up to 0.973. Therefore, gut dysbiosis characterizings gout could potentially serve as a noninvasive diagnostic tool for gout and may be a promising target of future preventive interventions.
- Gout,
- Gut microbiota,
- Febuxostat,
- Metabolism,
- Gene sequencing

These authors contribute equally to this work.

FullText(HTML)

References(49)

References

Abdou, R.M., Zhu, L., Baker, R.D., Baker, S.S., 2016. Gut microbiota of nonalcoholic fatty liver disease. Dig. Dis. Sci. 61, 1268-1281.

Ahmetoglu, A., Isik, Y., Aynaci, O., Bahadir, S., Aynaci, F.M., 2003. Proteus syndrome associated with liver involvement: case report. Genet. Couns. 14, 221-226.

Bajaj, J.S., Hylemon, P.B., Ridlon, J.M., Heuman, D.M., Daita, K., White, M.B., Monteith, P., Noble, N.A., Sikaroodi, M., Gillevet, P.M., 2012. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G675-G685.

Bernini, L.J., Simao, A.N.C., de Souza, C.H.B., Alfieri, D.F., Segura, L.G., Costa, G.N., Dichi, I., 2018. Effect of Bifidobacterium lactis HN019 on inflammatory markers and oxidative stress in subjects with and without the metabolic syndrome. Br. J. Nutr. 120, 645-652.

Bolyen, E., Rideout, J.R., Dillon, M.R., Bokulich, N.A., Abnet, C.C., Al-Ghalith, G.A., Alexander, H., Alm, E.J., Arumugam, M., Asnicar, F., 2019. Author correction: reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 1091.

Brahe, L.K., Le Chatelier, E., Prifti, E., Pons, N., Kennedy, S., Hansen, T., Pedersen, O., Astrup, A., Ehrlich, S.D., Larsen, L.H., 2015. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr. Diabetes 5, e159.

Bursill, D., Taylor, W.J., Terkeltaub, R., Abhishek, A., So, A.K., Vargas-Santos, A.B., Gaffo, A.L., Rosenthal, A., Tausche, A.K., Reginato, A., 2019. Gout, hyperuricaemia and crystal-associated disease network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Ann. Rheum. Dis. 78, 1592-1600.

Cendron, L., Berni, R., Folli, C., Ramazzina, I., Percudani, R., Zanotti, G., 2007. The structure of 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase provides insights into the mechanism of uric acid degradation. J. Biol. Chem. 282, 18182-18189.

Chen, R.J., Chen, M.H., Chen, Y.L., Hsiao, C.M., Chen, H.M., Chen, S.J., Wu, M.D., Yech, Y.J., Yuan, G.F., Wang, Y.J., 2017. Evaluating the urate-lowering effects of different microbial fermented extracts in hyperuricemic models accompanied with a safety study. J. Food Drug Anal. 25, 597-606.

Chu, Y., Huang, Y., Huang, Q., Xie, X., Wang, P., Li, J., Liang, L., He, X., Jiang, Y., Wang, M., Metagenomic study revealed the potential role of the gut microbiome in gout. NPJ Biofilms Microbiomes 7, 66.

Cusa, E., Obradors, N., Baldoma, L., Badia, J., Aguilar, J., 1999. Genetic analysis of a chromosomal region containing genes required for assimilation of allantoin nitrogen and linked glyoxylate metabolism in Escherichia coli. J. Bacteriol. 181, 7479-7484.

Dalbeth, N., Choi, H.K., Joosten, L.A.B., Khanna, P.P., Matsuo, H., Perez-Ruiz, F., Stamp, L.K., 2019. Gout. Nat. Rev. Dis. Primers 5, 69.

Day, R.O., Kamel, B., Kannangara, D.R., Williams, K.M., Graham, G.G., 2016. Xanthine oxidoreductase and its inhibitors: relevance for gout. Clin. Sci. (Lond) 130, 2167-2180.

Dehlin, M., Jacobsson, L., Roddy, E., 2020. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat. Rev. Rheumatol. 16, 380-390.

Dessein, P.H., Shipton, E.A., Stanwix, A.E., Joffe, B.I., Ramokgadi, J., 2000. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann. Rheum. Dis. 59, 539-543.

Edgar, R.C., 2010. Search and clustering orders of magnitude faster than blast. Bioinformatics 26, 2460-2461.

Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J.M., Topping, D.L., Suzuki, T., 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543-547.

Ghadimi, D., Yoness Hassan, M.F., Folster-Holst, R., Rocken, C., Ebsen, M., de Vrese, M., Heller, K.J., 2020. Regulation of hepcidin/iron-signalling pathway interactions by commensal bifidobateria plays an important role for the inhibition of metaflammation-related biomarkers. Immunobiology 225, 151874.

Guo, Z., Zhang, J., Wang, Z., Ang, K.Y., Huang, S., Hou, Q., Su, X., Qiao, J., Zheng, Y., Wang, L., 2016. Intestinal microbiota distinguish gout patients from healthy humans. Sci. Rep. 6, 20602.

He, K., Hu, Y., Ma, H., Zou, Z., Xiao, Y., Yang, Y., Feng, M., Li, X., Ye, X., 2016. Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways. Biochim Biophys Acta 1862, 1696-1709.

Hu, Y., Yang, X., Qin, J., Lu, N., Cheng, G., Wu, N., Pan, Y., Li, J., Zhu, L., Wang, X., 2013. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat. Commun. 4, 2151.

Huerta-Cepas, J., Forslund, K., Coelho, L.P., Szklarczyk, D., Jensen, L.J., von Mering, C., Bork, P., 2017. Fast genome-wide functional annotation through orthology assignment by eggnog-mapper. Mol. Biol. Evol. 34, 2115-2122.

Huerta-Cepas, J., Szklarczyk, D., Heller, D., Hernandez-Plaza, A., Forslund, S.K., Cook, H., Mende, D.R., Letunic, I., Rattei, T., Jensen, L.J., 2019. Eggnog 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses. Nucleic Acids Res 47, D309-D314.

Ignacio, A., Morales, C.I., Camara, N.O., Almeida, R.R., 2016. Innate sensing of the gut microbiota: modulation of inflammatory and autoimmune diseases. Front. Immunol. 7, 54.

Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., Hu, Y., Li, J., Liu, Y., 2015. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci. Rep. 5, 8096.

Jung, D.K., Lee, Y., Park, S.G., Park, B.C., Kim, G.H., Rhee, S., 2006. Structural and functional analysis of PucM, a hydrolase in the ureide pathway and a member of the transthyretin-related protein family. Proc. Natl. Acad. Sci. U. S. A. 103, 9790-9795.

Kashyap, P.C., Chia, N., Nelson, H., Segal, E., Elinav, E., 2017. Microbiome at the frontier of personalized medicine. Mayo. Clin. Proc. 92, 1855-1864.

Langmead, B., Salzberg, S.L., 2012. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359.

Li, D., Liu, C.M., Luo, R., Sadakane, K., Lam, T.W., 2015. Megahit: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics 31, 1674-1676.

Magoc, T., Salzberg, S.L., 2011. Flash: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957-2963.

Major, T.J., Dalbeth, N., Stahl, E.A., Merriman, T.R., 2018. An update on the genetics of hyperuricaemia and gout. Nat. Rev. Rheumatol. 14, 341-353.

Marchesi, J.R., Adams, D.H., Fava, F., Hermes, G.D., Hirschfield, G.M., Hold, G., Quraishi, M.N., Kinross, J., Smidt, H., Tuohy, K.M., 2016. The gut microbiota and host health: a new clinical frontier. Gut 65, 330-339.

Marino, P., Maggioni, M., Preatoni, A., Cantoni, A., Invernizzi, F., 1996. Liver abscesses due to listeria monocytogenes. Liver 16, 67-69.

Martin, M., 2011. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 3.

Nakatsu, Y., Seno, Y., Kushiyama, A., Sakoda, H., Fujishiro, M., Katasako, A., Mori, K., Matsunaga, Y., Fukushima, T., Kanaoka, R., 2015. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model. Am. J. Physiol. Gastrointest. Liver Physiol. 309, G42-G51.

Neogi, T., Jansen, T.L., Dalbeth, N., Fransen, J., Schumacher, H.R., Berendsen, D., Brown, M., Choi, H., Edwards, N.L., Janssens, H.J., 2015. 2015 gout classification criteria: an american college of rheumatology/european league against rheumatism collaborative initiative. Ann. Rheum. Dis. 74, 1789-1798.

Onetto, C., Rios, H., Domenech, A., Schiappacasse, G., Estay, C., 2013. Liver abscess due to listeria monocytogenes. Cir. Esp. 91, 267-269.

Ren, Z., Fan, Y., Li, A., Shen, Q., Wu, J., Ren, L., Lu, H., Ding, S., Ren, H., Liu, C., 2020. Alterations of the human gut microbiome in chronic kidney disease. Adv. Sci. (Weinh) 7, 2001936.

Robinson, P.C., 2018. Gout- an update of aetiology, genetics, co-morbidities and management. Maturitas 118, 67-73.

Rogers, H.W., Callery, M.P., Deck, B., Unanue, E.R., 1996. Listeria monocytogenes induces apoptosis of infected hepatocytes. J. Immunol. 156, 679-684.

Rognes, T., Flouri, T., Nichols, B., Quince, C., Mahe, F., 2016. Vsearch: a versatile open source tool for metagenomics. PeerJ 4, e2584.

Schnabl, B., Brenner, D.A., 2014. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146, 1513-1524.

Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., Huttenhower, C., 2011. Metagenomic biomarker discovery and explanation. Genome Biol 12, R60.

Shaaban, M.I., Abdelmegeed, E., Ali, Y.M., 2015. Cloning, expression, and purification of recombinant uricase enzyme from pseudomonas aeruginosa ps43 using Escherichia coli. J. Microbiol. Biotechnol. 25, 887-892.

Shao, T., Shao, L., Li, H., Xie, Z., He, Z., Wen, C., 2017. Combined signature of the fecal microbiome and metabolome in patients with gout. Front. Microbiol. 8, 268.

Vieira, A.T., Galvao, I., Amaral, F.A., Teixeira, M.M., Nicoli, J.R., Martins, F.S., 2015. Oral treatment with Bifidobacterium longum 51A reduced inflammation in a murine experimental model of gout. Benef. Microbes 6, 799-806.

Waller, A., Jordan, K.M., 2017. Use of febuxostat in the management of gout in the United Kingdom. Ther. Adv. Musculoskelet. Dis. 9, 55-64.

Wang, Y., Fei, Y., Liu, L., Xiao, Y., Pang, Y., Kang, J., Wang, Z., Polygonatum odoratum polysaccharides modulate gut microbiota and mitigate experimentally induced obesity in rats. Int. J. Mol. Sci.19, 3587.

Zhu, W., Lomsadze, A., Borodovsky, M., 2010. Ab initio gene identification in metagenomic sequences. Nucleic Acids Res 38, e132.

Relative Articles

Supplements(0)

Cited By

Proportional views